Adrian Howd Becomes CFO & CBO at BiVictriX Therapeutics

BiVictriX Therapeutics plc (AIM: BVX) has appointed Adrian Howd, Ph.D., as the combined Chief Financial Officer and Chief Business Officer. Alex Hughes will step down from his role as CFO on October 13.

Adrian brings more than 20 years of strategic financial and commercial experience in the biopharmaceutical industry to BiVictriX. He has held various financial roles, executive management positions, and board roles in the sector. Throughout his career, he has led multiple asset and corporate business development transactions and equity capital market fundraises totaling over €430 million. Adrian has substantial equity capital markets experience in the UK and overseas, gained during his previous senior roles at Berenberg Bank, ABN Amro, and Nomura.

Additionally, Adrian has served in senior management roles, including Chief Investment Officer and Chief Executive Officer at investment firm Malin plc, where he led the company to its debut on the Irish Stock Exchange in one of the largest European life science initial public offerings to date.

During his time at Malin, Adrian led investments in and served on the boards of UK-based companies Immunocore and Kymab. Both companies achieved significant exits, with Immunocore going public on NASDAQ and Kymab being acquired by Sanofi.

Tiffany Thorn, Chief Executive Officer of BiVictriX Therapeutics plc, expressed her excitement about Adrian’s appointment and highlighted his financial expertise and track record of success with UK oncology businesses. She thanked Alex for his contributions to the company and wished him well in his future endeavors.

Adrian Howd, the newly appointed CFO and CBO of BiVictriX Therapeutics plc, emphasized the company’s critical inflection point, citing compelling pre-clinical data for its lead asset and a growing technology pipeline. He expressed belief in the potential of the Bi-Cygni® Platform to transform cancer therapy and the company’s strategic options in the solid tumor space. Adrian looks forward to working with Tiffany and the BiVictriX team to maximize shareholder value from their scientific advancements.

Have you read?
6 ways leaders can create psychologically safe workplaces.
Story of a successful woman: interview with Founder of DHGATE Group Diane Wang.
Increased Productivity Starts with an Engaged Workforce.
What Michelangelo’s masterpieces can teach us about strategy development.
From Streams to Startups: Nurturing Human Capital Like Nature’s Precious Resource.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name